Navigate the Complex Path to Clinical Adoption

Built by commercial leaders who have taken diagnostic platforms from FDA clearance to national adoption.

12 questions · 4 minutes · Instant results · Confidential

OUR FRAMEWORK

The Architecture of Market Entry

A structured approach to turning regulatory milestones into repeatable market entry and clinical adoption for Dx and MedTech companies.

Evidence & Clinical Utility

Design clinical and economic evidence that demonstrates real-world utility for Dx and MedTech products.

Regulatory & Market Access

Sequence FDA pathways, reimbursement strategy, and payer engagement to unlock sustainable adoption.

Adoption Infrastructure

Build the commercial systems for physician engagement, channel placement, and scalable clinical uptake.

COMMERCIAL READINESS

Clearance Does Not Create Adoption

Regulatory progress advances the product. It does not establish commercial readiness.

Unclear launch sequencing
Evidence not payer-aligned
Channel decisions delayed
Pricing defined too late
Activity without repeatable adoption
Investor pressure increasing

This is where market entry risk begins.

The greatest risk in diagnostics is not scientific failure. It is the failure to reach clinical adoption. We build the bridge.

THE PATH TO CLINICAL ADOPTION

HOW WE WORK

Three Phases. One Architecture.

01 · Strategic Audit

Diagnose before you build. We identify the structural gaps between regulatory progress and clinical adoption, then sequence your next 90 days.

02 · Structural Design

Architecture, not advice. We design the pricing, channel, reimbursement, and evidence strategy that turns clearance into adoption.

03 · Guided Execution

From blueprint to adoption. We install the launch sequencing and field strategy that convert strategy into contracted clinical use.

WHO WE SUPPORT

For the Leaders Accountable for Adoption

Diagnostic Innovators

Your assay is validated. Now labs, payers, and physicians need a reason to adopt it. We build the evidence, coding, and channel strategy that gives them one.

Medical Device Firms

Clearance is in hand, but the clinical setting is crowded. We structure market entry, payer engagement, and launch so your device earns its place.

Strategic Investors

Before the next funding milestone, know whether the commercial plan holds up. We assess readiness, architecture, and adoption risk with an operator's eye.

THE SIX LAYERS

How ready are your six layers?

The Readiness Assessment scores your commercial architecture across all six layers in about four minutes.

NEXT STEP

Entering the Clinical Adoption Window?

Diagnostic companies often reach clinical validation without installing the commercial architecture required for adoption.

AdvisoryDx works with founders and investors to design market entry strategy before launch decisions become irreversible.

Start with the 4-minute assessment, or go straight to a 30-minute conversation.

STAY CURRENT

Subscribe to AdvisoryDx Insights

A monthly briefing on diagnostic commercialization architecture, regulatory sequencing, and adoption strategy.

Recent topics: FDA pathway sequencing, distributor evaluation frameworks, and reimbursement strategy.

Practical insights. No noise. Unsubscribe anytime.

NAVIGATE

RESOURCES

CONTACT

7901 4th St N, STE 300 St. Petersburg, FL 33702